PARP1-Selective Inhibitors Generate Excitement in Solid Tumors
PARP1-selective inhibitors could represent the next frontier and generation of PARP inhibitors in oncology, potentially reducing the hematologic toxicity demonstrated in both preclinical and clinical research with first-generation dual inhibitors of PARP1 …